+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoporosis Drugs Market by Drug Class (Bisphosphonate, Denosumab, Hormone Replacement Therapy), Route Of Administration (Injectable, Oral), Dosage Form, Distribution Channel, End User, Patient Gender - Global Forecast 2025-2030- Product Image
Osteoporosis Drugs Market by Drug Class (Bisphosphonate, Denosumab, Hormone Replacement Therapy), Route Of Administration (Injectable, Oral), Dosage Form, Distribution Channel, End User, Patient Gender - Global Forecast 2025-2030- Product Image
Sale

Osteoporosis Drugs Market by Drug Class (Bisphosphonate, Denosumab, Hormone Replacement Therapy), Route Of Administration (Injectable, Oral), Dosage Form, Distribution Channel, End User, Patient Gender - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674403
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The osteoporosis drugs market is evolving rapidly, driven by changing demographics, regulatory reforms, and innovation in both therapeutic approaches and supply chain strategies. Senior industry leaders must navigate these dynamic trends to optimize patient outcomes and achieve operational resilience within a complex global environment.

Market Snapshot: Osteoporosis Drugs at a Glance

The Osteoporosis Drugs Market grew from USD 8.77 billion in 2024 to USD 9.27 billion in 2025. It is expected to continue growing at a CAGR of 5.64%, reaching USD 12.19 billion by 2030. Market drivers include aging populations, advancements in bone health management, and increased emphasis on long-term therapy adoption. Stakeholders are responding to regulatory shifts, patient-centric initiatives, and biosimilar developments that are re-shaping the competitive landscape and fueling strategic partnerships.

Scope & Segmentation of the Osteoporosis Drugs Market

This comprehensive analysis explores every facet of the osteoporosis drugs market, detailing the major stakeholders, clinical practices, and regional variations that define industry dynamics.

  • Drug Classes: Bisphosphonates, Denosumab, Hormone Replacement Therapy, Parathyroid Hormone Analogs, Selective Estrogen Receptor Modulators
  • Routes of Administration: Injectable, Oral
  • Dosage Forms: Capsule, Injection, Solution, Tablet
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • End Users: Clinics, Home Healthcare, Hospitals
  • Patient Gender: Female, Male
  • Regional Coverage: Americas (including United States and key states, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (Major economies including United Kingdom, Germany, France, Italy, plus Gulf and African states); Asia-Pacific (China, India, Japan, Australia, and emerging Southeast Asian markets)
  • Company Landscape: Market tracked across Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Novartis AG, GlaxoSmithKline plc, Pfizer Inc., F. Hoffmann-La Roche Ltd, UCB S.A., AbbVie Inc., Teva Pharmaceutical Industries Ltd

Key Takeaways: Strategic Insights for Decision-Makers

  • Growing demand for innovative osteoporosis therapies is driven by patient-centered care models and continuous advancements in therapeutic pathways.
  • Personalized medicine and biomarker-based approaches are reshaping drug development, enabling tailored interventions aligned with unique risk profiles.
  • Collaborative ecosystems between pharmaceutical firms, academic institutions, and technology innovators are enhancing clinical research and real-world patient monitoring capabilities.
  • Biosimilar competition is fostering increased affordability and broadening access in previously underpenetrated markets, especially where cost constraints historically limited therapy uptake.
  • Healthcare modernization and expanded screening programs in the Asia-Pacific region are supporting earlier diagnosis and increased adoption of emerging therapies.
  • Efforts to enhance supply chain resilience, including localized manufacturing and dual-sourcing for active pharmaceutical ingredients, are becoming central to maintaining market stability.

Tariff Impact: Navigating the 2025 US Reforms

New United States tariff regulations, effective in 2025, add complexity to the osteoporosis drug supply chain. Manufacturers are reassessing sourcing strategies, considering cost implications of relocating operations or securing tariff-exempt sources. These reforms influence contract manufacturing, distribution, and pricing negotiations within both hospital and retail channels. In response, some firms are exploring domestic production, long-term supply contracts, or hedging mechanisms to manage costs and mitigate supply disruptions. Regulatory agencies have also indicated readiness to expedite approvals for facilities addressing potential capacity gaps, highlighting the ongoing need for proactive contingency planning.

Primary Keyword: Osteoporosis Drugs Market

Methodology & Data Sources

Report findings are based on desk research from peer-reviewed literature, regulatory filings, clinical trial databases, and financial reports. Complementary expert interviews with clinicians, payers, and supply chain leaders ensured nuanced, actionable insights. Targeted physician surveys captured real-world prescribing trends, while advanced analytics and data triangulation reconciled variations across sources for robust results.

Why This Report Matters

  • Enables informed strategy for stakeholders facing evolving regulatory, competitive, and operational challenges in osteoporosis treatment.
  • Guides investment decisions through in-depth segmentation and regional analysis, supporting both established leaders and emerging entrants navigating market access barriers.

Conclusion

As demographic, regulatory, and innovation trends converge, senior decision-makers require clear, actionable intelligence to optimize business strategy and drive sustainable growth in the osteoporosis drugs sector. This report offers the clarity and depth needed to capitalize on emerging opportunities and future-proof organizational resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging role of sclerostin inhibitors in reducing fracture risk among elderly patients
5.2. Adoption of digital health monitoring tools for tracking patient adherence to osteoporosis medications
5.3. Impact of biosimilar teriparatide entry on pricing strategies of established osteoporosis brands
5.4. Clinical outcomes and market uptake of romosozumab following cardiovascular safety data updates
5.5. Integration of genetic risk assessment in personalized osteoporosis treatment decision making processes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Osteoporosis Drugs Market, by Drug Class
8.1. Introduction
8.2. Bisphosphonate
8.3. Denosumab
8.4. Hormone Replacement Therapy
8.5. Parathyroid Hormone Analog
8.6. Selective Estrogen Receptor Modulator
9. Osteoporosis Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
10. Osteoporosis Drugs Market, by Dosage Form
10.1. Introduction
10.2. Capsule
10.3. Injection
10.4. Solution
10.5. Tablet
11. Osteoporosis Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Osteoporosis Drugs Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
13. Osteoporosis Drugs Market, by Patient Gender
13.1. Introduction
13.2. Female
13.3. Male
14. Americas Osteoporosis Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Osteoporosis Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Osteoporosis Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Amgen Inc.
17.3.2. Eli Lilly and Company
17.3.3. Merck & Co., Inc.
17.3.4. Novartis AG
17.3.5. GlaxoSmithKline plc
17.3.6. Pfizer Inc.
17.3.7. F. Hoffmann-La Roche Ltd
17.3.8. UCB S.A.
17.3.9. AbbVie Inc.
17.3.10. Teva Pharmaceutical Industries Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. OSTEOPOROSIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. OSTEOPOROSIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. OSTEOPOROSIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. OSTEOPOROSIS DRUGS MARKET: RESEARCHAI
FIGURE 28. OSTEOPOROSIS DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. OSTEOPOROSIS DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. OSTEOPOROSIS DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OSTEOPOROSIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY BISPHOSPHONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY BISPHOSPHONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DENOSUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DENOSUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY PARATHYROID HORMONE ANALOG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY PARATHYROID HORMONE ANALOG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY SELECTIVE ESTROGEN RECEPTOR MODULATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY SELECTIVE ESTROGEN RECEPTOR MODULATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OSTEOPOROSIS DRUGS MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES OSTEOPOROSIS DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 88. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 89. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 92. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 93. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 98. CANADA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 99. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 101. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 161. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 162. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 163. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 166. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 167. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 172. GERMANY OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 173. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 174. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 175. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 184. FRANCE OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 197. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 198. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 199. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 208. ITALY OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 209. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 210. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 211. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 220. SPAIN OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 257. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 258. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 259. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 262. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 263. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 268. DENMARK OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 281. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 282. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 283. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 286. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 287. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 292. QATAR OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 293. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 298. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 299. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 304. FINLAND OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 329. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 330. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 331. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 332. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 333. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 334. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 335. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 340. EGYPT OSTEOPOROSIS DRUGS MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 341. TU

Samples

Loading
LOADING...

Companies Mentioned

  • Amgen Inc.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Novartis AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • UCB S.A.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.19 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bisphosphonates Market by Type (Alendronate, Ibandronate, Risedronate), Administration Route (Oral, Parenteral), Dosage Form, Application, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Bisphosphonates Market by Type (Alendronate, Ibandronate, Risedronate), Administration Route (Oral, Parenteral), Dosage Form, Application, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Osteoporosis Drugs Market Size, Share, & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030 - Product Image

Osteoporosis Drugs Market Size, Share, & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030 - Product Image

Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Osteoporosis Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Osteoporosis Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Image

Osteoporosis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Osteoporosis Drug Market

The Osteoporosis Drug market is a subset of the pharmaceutical industry focused on the development of drugs to treat and prevent osteoporosis. Clinical trials are an important part of the drug development process, as they provide evidence of the safety and efficacy of a drug. Clinical trials are conducted in phases, with each phase providing more detailed information about the drug's safety and efficacy. The results of these trials are used to determine whether the drug should be approved for use by regulatory authorities. The Osteoporosis Drug market is highly competitive, with many companies vying for a share of the market. Companies in the market include Amgen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.